NOV 13, 2018 07:34 PM PST

Yin & Yang: The Duality of Cancer-Associated Fibroblasts in Pancreatic Cancer

Pancreatic Cancer is a devastating disease. Fifty-five thousand new patients were diagnosed this year in the United States (1). It is painful and usually diagnosed too late for effective treatment with currently available therapies. Researchers in the Tuveson Lab at Cold Spring Harbor Laboratory are hoping to change the fate of those diagnosed with pancreatic cancer by targeting the cancer associated fibroblasts (CAFs) that support tumor growth.

Pancreatic cancer cells (red) surrounded by a vast stroma (cyan). Nuclei are in blue, and this image was created by Neelima Shah and Edna Cukierman.

Pancreatic Ductal Adenocarcinoma (PDAC), the most common type of pancreatic cancer, has a 1 year survival rate of 20% and a 5 year survival rate of less than half that (2). Prognosis is so poor because treatment is complicated by the lack of blood vessels in the tumor and the high rate of metastasis. Without a blood supply, chemotherapies can’t reach or target cancerous cells, and PDAC’s location near ducts allows cancerous cells to slough off and establish satellite tumors at other locations.

Like all solid tumors, PDAC is made up of both cancerous cells and a support system, the stroma (3). However, PDAC is unique in that close to 90 percent of the tumor mass is stroma, and it is in the stroma that CAFs secrete factors that promote tumor progression and metastasis. (4).

Previously, CAFs were found to be to pro-tumorigenic. However, studies and clinical trials designed to target CAFs failed to inhibit the progression of PDAC, and in some cases exacerbated it (Biffi et al). This suggests that there must be heterogeneity in the CAF population which is exactly what Biffi et al saw. They demonstrated that PDAC stroma contains two subsets of CAFs, one inflammatory (iCAF) located close to the cancerous cells, and the other myofibroblastic (myCAF) located more distally.

In this study they built on that observation and determined the factors which control the differentiation of each type of CAF. Following single cell RNA sequencing of both iCAFs and myCAFs, they used biochemistry and learned that while IL-1 signaling turns on pathways in CAF precursors that cause differentiation into iCAFs, TGF-β downregulates the IL-1 receptor (IL-1R) resulting in those precursors adopting a myofibroblastic phenotype (myCAFs).

But they didn’t stop there. Using a mouse model which recapitulates PDAC, they inhibited signaling downstream of the IL-1R and not only saw a significant reduction in tumor burden, but the small, remaining tumors contained more tumor suppressive myofibroblastic CAFs.

So, the previous clinical trials that inhibited CAFs may have failed because they inhibited both the inflammatory iCAFs and the tumor suppressive myCAFs. It is possible that by specifically targeting iCAFs in patients’ pancreatic cancers, a diagnosis of pancreatic cancer will no longer be a death sentence.

Learn more about cancer-associated fibroblasts from the video

 

Sources: 1) cancer.org; 2) pancreatic.org; 3) Journal of Thoracic Oncology; 4) Genes & Diseases; 5) Journal of Experimental Medicine

About the Author
  • Aleishia is a freelance medical/science writer that specializes in research-oriented content. Contact her for work.
You May Also Like
OCT 22, 2019
Immunology
OCT 22, 2019
A Novel Therapeutic Target for a Severe Bacterial Infection
Pseudomonas aeruginosa (Pa) is an opportunistic human pathogen that can cause severe illness and even death in people that are hospitalized or have weakene...
OCT 22, 2019
Health & Medicine
OCT 22, 2019
Fourth-Generation Rapid Diagnostic Tests for Acute HIV-1 Infections
The ability to diagnose an acute HIV-1 infection before there are detectable antibodies to HIV 1/2 is critical to making an early diagnosis and getting the...
OCT 22, 2019
Genetics & Genomics
OCT 22, 2019
Smoking Dads Alter Immune Gene Epigenetics & Increase Risk of Asthma in Kids
Using a group of 1,629 couples, scientists in Taiwan have analyzed the impact of paternal smoking on children....
OCT 22, 2019
Immunology
OCT 22, 2019
Making Opioids Safer
The opioid crisis results in 130 American deaths every day, and both prescribed and synthetic opioids are at the core of the epidemic.  Any other drug...
OCT 22, 2019
Immunology
OCT 22, 2019
AI Not Ready To Predict Acute Kidney Injury
An international group of scientists from the U.S. and U.K. published new research in Nature about the effectiveness of AI in predicting Acute Kidney Injur...
OCT 22, 2019
Health & Medicine
OCT 22, 2019
Study Links High Birth Weight to Risk of Allergies
Researchers from the University of Adelaide, Australia have linked the risk of developing childhood food allergies and eczema to heavier birth weight. The...
Loading Comments...